Share capital increase

Share capital increase

On 29 October 2010 the general assembly in DiaGenic ASA resolved a
private placement of 140 million new shares and a subsequent offering of
up to 60 million new shares, both at a subscription price of NOK 0.50
per share. The share capital increase from the subsequent offering of 60
million new shares has now been registered with the Norwegian Register
of Business Enterprises. Following the registration, DiaGenic's share
capital is NOK 13,511,826, divided into 270,236,520 shares, each with a
nominal value of NOK 0.05. The Articles of Association of the Company
have been revised accordingly. Please find attached updated company
certificate.

The new shares in DiaGenic ASA are from now on tradable on Oslo Børs.

This information is subject of the disclosure requirements acc. to §5-12
vphl (Norwegian Securities Trading Act).

Contact:

Erik Christensen, CEO

Telephone: 47 95939918

e-mail: erik.christensen@diagenic.com